Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
autoimmune disease metabolic disorder |
| gptkbp:affects |
adolescents
adults children pancreas |
| gptkbp:alsoKnownAs |
gptkb:juvenile_diabetes
insulin-dependent diabetes mellitus |
| gptkbp:associatedWith |
gptkb:HLA_genes
autoantibodies |
| gptkbp:cannot_be_prevented |
true
|
| gptkbp:cause |
gptkb:hypoglycemia
hyperglycemia |
| gptkbp:causedBy |
obesity
lifestyle factors autoimmune destruction of beta cells |
| gptkbp:characterizedBy |
insulin deficiency
|
| gptkbp:complication |
gptkb:cardiovascular_disease
gptkb:diabetic_ketoacidosis gptkb:nephropathy peripheral neuropathy retinopathy |
| gptkbp:diagnosedBy |
blood glucose test
HbA1c test |
| gptkbp:firstDescribed |
19th century
|
| https://www.w3.org/2000/01/rdf-schema#label |
Type 1 Diabetes Mellitus
|
| gptkbp:ICD-10_code |
E10
|
| gptkbp:incidence |
increasing worldwide
|
| gptkbp:managedBy |
physical activity
dietary management blood glucose monitoring |
| gptkbp:monitors |
continuous glucose monitor
fingerstick blood glucose test |
| gptkbp:onset |
childhood
adolescence |
| gptkbp:prevalence |
less common than Type 2 Diabetes
|
| gptkbp:requires |
lifelong management
|
| gptkbp:riskFactor |
family history
genetic predisposition environmental factors |
| gptkbp:symptom |
fatigue
weight loss polydipsia polyuria |
| gptkbp:treatment |
gptkb:insulin
insulin therapy multiple daily injections artificial pancreas |
| gptkbp:bfsParent |
gptkb:D004053
|
| gptkbp:bfsLayer |
7
|